Clinical Trials Logo

Clinical Trial Summary

This study will consist of a randomized experimental group and a control group, In addition to the control and experimental group, there will also be a non-randomized motivated experimental group. Approximately 75 males and females from the ages of 18 to 80 will take part in this study. Subjects will be randomly divided into a Control and Experimental Group. Subjects for the control and experimental group will be recruited from a Tony Robbins Facebook page, and subjects in the experimental group (DWD Group) will be admitted to the Tony Robbins Date With Destiny Event (December 2019) in West Palm Beach for free, while the subjects randomly assigned to the control group, will not attend the event, but instead be required to a Gratitude Journaling experiment (Three Good Things Intervention). Psychological assessment surveys will be taken before the event, directly after the event, and one month following the event. The control group will take the psychological assessment before beginning journaling, directly after completing journaling, and one month following completion of journaling.


Clinical Trial Description

Background:

A Pubmed or Google Scholar search reveals zero peer-reviewed articles examining Robbins' events, techniques, or principles, despite Robbins' enormous impact on culture, psychology, and individual lives. Furthermore, only poorly conceptualized studies testing clinically irrelevant hypotheses were ever conducted on Neurolinguistic Programming (NLP), a constitutive framework for part of Robbins' methodologies. Due to the intimate link between beliefs, wellness, and disease, the investigators hypothesize that an intervention focused on belief-restructuring, trauma release, psychoeducation, hope, inspiration, & social support like participation in a Tony Robbins' event (e.g. DWD) will demonstrate significant mental and physical health outcomes.

The investigators hope to obtain a better understanding of:

1. Whether Tony Robbins' DWD improves affect, depression symptoms, and well-being.

2. Setup collaboration infrastructure and generate hypotheses for a future randomized controlled trial to determine short- and long-term physiological and health effects of Tony Robbins' interventions.

Importance:

Tony Robbins, inventor of the term, life coach, and a coach to leaders around the world, regularly sells out 14,000 person arenas worldwide to talk about psychology, mental health, and wellbeing, and his website alone averages 1,000,000 unique visitors per month. Yet, a literature search through PubMed & Google Scholar reveals 0 empirical studies of Tony Robbins' work. Considering patients prefer psychotherapy over medication, there are a rich set of interventions to draw from Tony Robbins that could prove to be effective, accessible, and affordable in treating & preventing mental health issues including depression and suicide. Understanding the science of Tony Robbins' work could provide new theoretical frameworks and clinical interventions to inform non-pharmacological approaches to mental health.

Methodology:

This study will consist of a randomized experimental group and a control group, In addition to the control and experimental group, there will also be a non-randomized motivated experimental group. Approximately 75 males and females from the ages of 18 to 80 will take part in this study. Subjects will be randomly divided into a Control and Experimental Group. Subjects for the control and experimental group will be recruited from a Tony Robbins Facebook page, and subjects in the experimental group (DWD Group) will be admitted to the Tony Robbins Date With Destiny Event (December 2019) in West Palm Beach for free, while the subjects randomly assigned to the control group, will not attend the event, but instead be required to a Gratitude Journaling experiment (Three Good Things Intervention).

Subjects will be recruited by posting a Survey Monkey link on the DWD Facebook page as well as via email and direct referral. All participants will complete a consent form and take a brief eligibility survey administered digitally through Survey Monkey's secure system. Both groups will be given surveys before DWD, immediately after DWD to assess acute changes, and after 1 month after DWD to assess longitudinal changes. The experimental group will attend DWD. After attending DWD, the experimental group will be asked to continue practicing "Priming " daily for a month. A One-page "priming" cheat sheet will be given to the subjects in the experimental group. The control group will be asked to engage in gratitude journaling (protocol below) every day for a month. The control group will NOT attend the event.

A third group called the Motivated Experimental Group (M Experimental) will consist of participants who registered and paid for Tony Robbins Date with Destiny (DWD). They are chosen as the motivated experimental as they will be paying full price for the event. Subjects will be recruited at the event, as well as through the facebook group. Two investigators will follow up with subjects monthly by phone to assure consistency.

All surveys will be administered electronically through survey monkey. Informed Consent forms will also be provided electronically to all subjects. All subjects that participate in this study will receive a free book and audiobook, regardless of the group they were in upon completion of the study.

Study variables

Primary variables:

- Mental Health (depression, anxiety, stress) scores.

IRBs will need to be Electronically Signed by all participants. All Variables will be collected electronically over Survey Monkey. All questions will be extracted and worded directly off of the physical copy of each questionnaire into Survey Monkey. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04172051
Study type Interventional
Source Applied Science & Performance Institute
Contact
Status Completed
Phase N/A
Start date November 25, 2019
Completion date January 14, 2020

See also
  Status Clinical Trial Phase
Completed NCT04122482 - An Online Course for Improving Knowledge and Access to Mental Health Accommodations in Canadian Enterprises N/A
Completed NCT04085861 - Mental Health in Dancers; an Intervention Study N/A
Recruiting NCT06060210 - Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion Phase 4
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Recruiting NCT06065787 - NeuroGlove Anxiety and Depression Study N/A
Active, not recruiting NCT04583891 - Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design N/A
Completed NCT05554042 - Kintsugi Voice Device Study
Not yet recruiting NCT06162624 - Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons N/A
Completed NCT02954250 - Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide Early Phase 1
Recruiting NCT05647499 - Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study N/A
Completed NCT03980873 - Cognitive-Behavioral Therapy for Young Adult Lesbian, Gay and Bisexual: Transdiagnostic Minority Stress Approach N/A
Completed NCT04422327 - The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome Phase 1/Phase 2
Completed NCT05368155 - Chronic Pelvic Pain and Education Skills Training for Women Veterans N/A
Completed NCT05455905 - Voice Biomarkers Predictive of Depression and Anxiety
Completed NCT03272516 - Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients N/A
Not yet recruiting NCT06027047 - Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)
Not yet recruiting NCT05535101 - Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder N/A
Recruiting NCT04418115 - Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option? N/A
Completed NCT04905524 - Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP) N/A
Recruiting NCT03953118 - Azithromycin for Meibomian Gland Disease Phase 4